High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021.
Saved in:
| Title: | High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021. |
|---|---|
| Authors: | Namayanja GA; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Da Silva JF; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Elur B; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Nasirumbi PM; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Raizes E; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Ssempiira J; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Nazziwa E; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Nabukenya M; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda., Sewanyana I; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda., Balaba J; Monitoring and Evaluation Technical Support, Makerere University School of Public Health, Kampala, Uganda., Ntale J; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Calnan J; Office of Health and HIV, United States Agency for International Development, Kampala, Uganda., Birabwa E; Walter Reed Army Institute of Research, US Mission, Kampala, Uganda., Akao J; United States Department of Defense, US Mission, Kampala, Uganda., Mwangi C; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Naluguza M; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Ahimbisibwe A; AIDS Control Program, Ministry of Health, Kampala, Uganda., Katureebe C; AIDS Control Program, Ministry of Health, Kampala, Uganda., Nabadda S; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda., Nelson L; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda., Dirlikov E; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda. |
| Source: | PloS one [PLoS One] 2024 Jun 26; Vol. 19 (6), pp. e0305129. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38923981 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Namayanja+GA%22">Namayanja GA</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Da+Silva+JF%22">Da Silva JF</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.<br /><searchLink fieldCode="AU" term="%22Elur+B%22">Elur B</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nasirumbi+PM%22">Nasirumbi PM</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Raizes+E%22">Raizes E</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.<br /><searchLink fieldCode="AU" term="%22Ssempiira+J%22">Ssempiira J</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nazziwa+E%22">Nazziwa E</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nabukenya+M%22">Nabukenya M</searchLink>; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Sewanyana+I%22">Sewanyana I</searchLink>; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Balaba+J%22">Balaba J</searchLink>; Monitoring and Evaluation Technical Support, Makerere University School of Public Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Ntale+J%22">Ntale J</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Calnan+J%22">Calnan J</searchLink>; Office of Health and HIV, United States Agency for International Development, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Birabwa+E%22">Birabwa E</searchLink>; Walter Reed Army Institute of Research, US Mission, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Akao+J%22">Akao J</searchLink>; United States Department of Defense, US Mission, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Mwangi+C%22">Mwangi C</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Naluguza+M%22">Naluguza M</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Ahimbisibwe+A%22">Ahimbisibwe A</searchLink>; AIDS Control Program, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Katureebe+C%22">Katureebe C</searchLink>; AIDS Control Program, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nabadda+S%22">Nabadda S</searchLink>; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nelson+L%22">Nelson L</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Dirlikov+E%22">Dirlikov E</searchLink>; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Kampala, Uganda. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2024 Jun 26; Vol. 19 (6), pp. e0305129. <i>Date of Electronic Publication: </i>2024 Jun 26 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38923981 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0305129 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0305129 Titles: – TitleFull: High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Namayanja GA – PersonEntity: Name: NameFull: Da Silva JF – PersonEntity: Name: NameFull: Elur B – PersonEntity: Name: NameFull: Nasirumbi PM – PersonEntity: Name: NameFull: Raizes E – PersonEntity: Name: NameFull: Ssempiira J – PersonEntity: Name: NameFull: Nazziwa E – PersonEntity: Name: NameFull: Nabukenya M – PersonEntity: Name: NameFull: Sewanyana I – PersonEntity: Name: NameFull: Balaba J – PersonEntity: Name: NameFull: Ntale J – PersonEntity: Name: NameFull: Calnan J – PersonEntity: Name: NameFull: Birabwa E – PersonEntity: Name: NameFull: Akao J – PersonEntity: Name: NameFull: Mwangi C – PersonEntity: Name: NameFull: Naluguza M – PersonEntity: Name: NameFull: Ahimbisibwe A – PersonEntity: Name: NameFull: Katureebe C – PersonEntity: Name: NameFull: Nabadda S – PersonEntity: Name: NameFull: Nelson L – PersonEntity: Name: NameFull: Dirlikov E IsPartOfRelationships: – BibEntity: Dates: – D: 26 M: 06 Text: 2024 Jun 26 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 19 – Type: issue Value: 6 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |